| | |||||
| lung cancer | |||||
| 新闻 | |||||
| FDA Rejects Request to Approve Novel Drug Combination in NSCLC - Cure Today ... not approve sintilimab plus the chemotherapy pemetrexed and platinum-based chemotherapy for patients with non-squamous non-small cell lung cancer.
| |||||
| Double lung transplant saves US man with terminal cancer - JIJI PRESS Lung transplantation for lung cancer is extremely uncommon with few cases reported, Ankit Bharat, chief of thoracic surgery at Northwestern Medicine, ...
| |||||
| High D-dimer levels tied to higher risk of VTE and death in lung cancer: Study - Medical Dialogues High D-dimer levels (vs low levels) are tied to a higher risk for lung cancer death, according to a recent study published in the Frontiers of ...
| |||||
| Biologists discover gene deletion behind abnormality in blood cancer cells - News Medical The research was supported by the Discovery Grant from the Kuni Foundation, as well as grants from the National Heart, Lung and Blood Institute at the ...
| |||||
| Lung Cancer Diagnostic Tests Market Size by Drives, Product Sales, Revenue ... - ChattTenn Sports The report also provides a comprehensive analysis of the sales volume, revenue, gross margin, and price growth in the Lung Cancer Diagnostic Tests ...
| |||||
| New approach to help low- and middle-income countries reduce premature mortality from NCDs ... pandemic has disproportionately affected people living with non-communicable diseases like heart disease, cancer, and chronic lung disease.
| |||||
| Daily Aspirin Fails to Improve Disease-Free Survival in Breast Cancer - Targeted Oncology "Although inflammation may still play a key role in cancer, it's also important to remember that aspirin may have different effects in other cancers, ...
| |||||
| Frontline Itolizumab Shows Durable Response Against aGVHD - Targeted Oncology Corey Cutler, MD, MPH, FRCPC, of the Dana-Farber Cancer Institute presented these findings at the 48th Annual Meeting of the European Group for ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment